Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Lianqun Qiu Image

      Lianqun Qiu, MD, PhD

      Department of Hematopathology, Division of Pathology-Lab Medicine Div

      Present Title & Affiliation

      Primary Appointment

      Assistant Professor, Hematopathology, Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas

      Education & Training

      Degree-Granting Education

      The National University of Singapore, Singapore, SG, Pathology, PhD
      Fudan University Shanghai Medical College, Shanghai, CN, Clinical Medicine, MD
      Fudan University Shanghai Medical College, Shanghai, CN, Internal Medicine, MSc

      Postgraduate Training

      2020-2022Clinical Fellow, Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
      2016-2020Resident, Anatomical and Clinical Pathology, UT Health San Antonio, San Antonio, Texas
      2009-2016Research Fellow, Post-transcriptional gene expression group, National Institute of Environmental Health Sciences, National Institutes of Health, Durham, NC
      2004-2009Postgraduate Fellow, Inflammation and Gene Regulation, Singapore Immunology Network; Genome Institute of Singapore, Singapore
      null-nullPracticing physician, Internal Medicine/Nephrology, Zhong Shan Hospital, Fudan University Shanghai Medical College, Shanghai

      Licenses & Certifications

      2024Lianqun Qiu
      2022Lianqun Qiu
      2019Lianqun Qiu

      Experience & Service

      Faculty Academic Appointments

      Assistant Professor, Laboratory Medicine and Pathology, University of Washington, Seattle, WA, 2022 - 2024

      Intramural Institutional Committee Activities

      member, Education Strategic Committee, The University of Texas MD Anderson Cancer Center, 2025 - Present

      Extramural Institutional Committee Activities

      member, Quality and Standards Committee, The International Clinical Cytometry Society, 2025 - Present

      member, Award Committee, Chinese American Pathologists Association, 2025 - Present

      Honors & Awards

      2024 - 2025Excellence of Teaching Award, Department of Hematopathology, UT MD Anderson Cancer Center

      Professional Memberships

      International Clinical Cytometry Society

      2023 - Present

      Washington State Medical Association

      2023 - 2024

      Society of Hematopathology

      2022 - Present

      Chinese American Pathologists Association

      2017 - Present

      United States and Canadian Academy of Pathology

      2016 - Present

      American Society of Clinical Pathology

      2016 - Present

      College of American Pathologists

      2016 - Present

      The American Association of Immunologists

      2012 - 2015

      Selected Presentations & Talks

      National Presentations

      1. 2022. Clinicopathologic and cytogenetic features of blastoid high-grade B-cell lymphoma. Conference. United States and Canadian Academy of Pathology (USCAP) 2022 annual meeting, Los Angeles, CA, March 19-24, 2022 (Platform), US.

      International Presentations

      1. 2024. Immunophenotypic shift and clonal evolution during NPM1-muated AML MRD follow-up. Panelist. University of Washington-Australia Flow cytometry Regional Conference, US.
      2. 2005. Role of cell cycle regulatory protein in the progressive course of human IgA nephropathy. Invited. 3rd World Congress of Nephrology, Singapore, June 26-30, 2005, US.
      Read More
      Less

      Selected Publications

      Peer-Reviewed Articles

      1. Wang WJ, Wang SA, Fang H, Jorgensen JL, Hu S, Qiu L, Xu J, Medeiros LJ, Wang W. Mature T-cell leukemia/lymphoma with an NK-like immunophenotype: A report of 7 cases. Cytometry B Clin Cytom, 2026. e-Pub 2026. PMID: 41721448.
      2. Li S, Short NJ, Wang W, Ling J, Qiu L, Xu J, Wang WJ, Jia F, Tang G, Karrar O, Maroun MM, Medeiros LJJ, Ravandi F, Wang SA. Prospective Feasibility Study of Peripheral Blood for MRD Detection in Acute Myeloid Leukemia by Flow Cytometry. Blood Adv, 2026. e-Pub 2026. PMID: 41649796.
      3. Qiu L, Love JE, Simonson W, Fromm JR, Cherian S. CD4 antigen loss in bronchoalveolar lavage fluid with neutrophilia and infectious organisms: A diagnostic pitfall when analyzing T-cell subsets by flow cytometry. Am J Clin Pathol 164(3):273-277, 2025. e-Pub 2025. PMID: 40418722.
      4. Qiu, L, Thakral, B. Intrasinusoidal pleomorphic mantle cell lymphoma mimicking intravascular large B-cell lymphoma. Blood 146(7):897, 2025. e-Pub 2025. PMID: 40811000.
      5. Shuyu, E, Medeiros, LJ, Fang, H, Li, S, Tang, G, Wang, S, Wang, W, Yin, CC, You, MJ, Iyer, SP, Malpica Castillo, LE, Qiu, L, Tang, Z, Wei, Q, Lin, P, Xu, J. Low CD25 in ALK+ Anaplastic Large Cell Lymphoma Is Associated with Older Age, Thrombocytopenia, and Increased Expression of Surface CD3 and CD8. Cancers 17(11), 2025. e-Pub 2025. PMID: 40507248.
      6. Kim DH, Medeiros LJ, Xu J, Tang G, Qiu L, Wang SA, Ok CY, Wang W, Yin CC, You MJ, Garces S, Lin P, Li S. Diffuse Large B-Cell Lymphoma/High-Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements: A Study of 60 Cases. Mod Pathol 38(5):100710, 2025. e-Pub 2025. PMID: 39805522.
      7. Xu J, Kim DH, Wang W, Li S, Lin P, Tang G, Konoplev S, Qiu L, Fang H, Garces S, Leventaki V, E S, Medeiros LJ, Wang SA. Flow cytometric immunophenotypic features of acute myeloid leukemia with mast cell differentiation. Am J Clin Pathol, 2024. e-Pub 2024. PMID: 39244687.
      8. Marques-Piubelli ML, Lyapichev KA, Fnu A, Adrada B, Stewart J, Hunt KK, Clemens MW, Iyer S, Wu Y, El Hussein S, Xu J, Ok CY, Li S, Pierson DM, Ferrufino-Schmidt MC, Nahmod KA, Yoga A, Hunsicker L, Evans MG, Resetkova E, Qiu L, Khanlari M, Garces SA, Bueso-Ramos CE, Medeiros LJ, Miranda RN. The Spectrum of Non-neoplastic Changes Associated With Breast Implants: Histopathology, Imaging, and Clinical Significance. Am J Surg Pathol 48(6):e43-e64, 2024. e-Pub 2024. PMID: 38451836.
      9. Qiu L, Naresh KN. Mature plasmacytoid dendritic cell proliferation in association with mixed-phenotype acute leukemia, T/myeloid. Blood 143(6):561, 2024. e-Pub 2024. PMID: 38329773.
      10. Rivera D, Cui W, Gao J, Peker D, Zhang QY, Dewar R, Qiu L, Konoplev S, Hu Z, Sasaki K, Hu AY, E S, Liu M, Fang H, Wang W, Tang G, Apperley JF, Hochhaus A, Cortes JE, Khoury JD, Medeiros LJ, Jabbour E, Hu S. Aleukemic Chronic Myeloid Leukemia Without Neutrophilia and Thrombocytosis: A Report From the BCR::ABL1 Pathology Group. Mod Pathol 37(2):100406, 2024. e-Pub 2024. PMID: 38104892.
      11. Qiu L, Lin P, Khanlari M, Xu J, Cohen EN, Garces S, Miranda RN, Wang W, Fang H, Bueso-Ramos CE, Medeiros LJ, Li S. The Clinicopathologic Features and Molecular Signatures of Blastoid High-Grade B Cell Lymphoma, Not Otherwise Specified. Mod Pathol 36(12):100349, 2023. e-Pub 2023. PMID: 37820764.
      12. Qiu L, Tang G, Li S, Vega F, Lin P, Wang SA, Wang W, Iyer SP, Malpica L, Miranda RN, Konoplev S, Tang Z, Fang H, Medeiros LJ, Xu J. DUSP22 rearrangement is associated with a distinctive immunophenotype but not outcome in patients with systemic ALK-negative anaplastic large cell lymphoma. Haematologica 108(6):1604-1615, 2023. e-Pub 2023. PMID: 36453104.
      13. Li S, Qiu L, Xu J, Lin P, Ok CY, Tang G, McDonnell TJ, James You M, Khanlari M, Miranda RN, Medeiros LJ. High-grade B-cell lymphoma (HGBL)-NOS is clinicopathologically and genetically more similar to DLBCL/HGBL-DH than DLBCL. Leukemia 37(2):422-432, 2023. e-Pub 2023. PMID: 36513804.
      14. Qiu L, Wang SA, Tang G, Wang W, Lin P, Xu J, Yin CC, Khanlari M, Medeiros LJ, Li S. Blastoid B-Cell Neoplasms: Diagnostic Challenges and Solutions. Cancers (Basel) 15(3), 2023. e-Pub 2023. PMID: 36765805.
      15. Qiu L, Quesada AE. Lymphoplasmacytic lymphoma with IgG paraprotein and extensive plasmacytic differentiation mimicking plasma cell neoplasm. Blood 140(26):2857, 2022. e-Pub 2022. PMID: 36580339.
      16. Agarwal AN, Nania J, Qiu L, Lewis B, Mais DD. Impact of Liver Biopsy Size on Histopathologic Evaluation of Liver Allograft Rejection. Arch Pathol Lab Med 146(12):1530-1534, 2022. e-Pub 2022. PMID: 35271695.
      17. Qiu L, Nwogbo OV, Medeiros LJ, Thakral B, Li S, Xu J, You MJ, Wang W, Quesada AE, Ramos CB, McDonnell TJ, Thomas SK, Lin P. Lymphoplasmacytic lymphoma with IgG or IgA paraprotein: a study of 29 cases including cases that can mimic plasma cell neoplasms. Hum Pathol 130:47-57, 2022. e-Pub 2022. PMID: 36244464.
      18. Qiu L, Nunez CA, Tang G, Cuglievan B, Issa GC, Wang SA, Medeiros LJ, Thakral B. A rare case of acute megakaryoblastic leukemia with t(11;17)(q23;q21) and KMT2A::MLLT6 fusion. Ann Hematol 101(7):1579-1581, 2022. e-Pub 2022. PMID: 35091795.
      19. Qiu L, Quesada AE. Plasma cell leukemia with small cell morphology. Blood 139(25):3667, 2022. e-Pub 2022. PMID: 35737405.
      20. Khanlari M, Li S, Miranda RN, Iyer S, Konoplev S, Lin P, Yin CC, Tang G, Qiu L, Vega F, Medeiros LJ, Xu J. Small cell/lymphohistiocytic morphology is associated with peripheral blood involvement, CD8 positivity and retained T-cell antigens, but not outcome in adults with ALK+ anaplastic large cell lymphoma. Mod Pathol 35(3):412-418, 2022. e-Pub 2022. PMID: 34628481.
      21. Khanlari M, Medeiros LJ, Lin P, Xu J, You MJ, Tang G, Yin CC, Wang W, Qiu L, Miranda RN, Bueso-Ramos CE, Li S. Blastoid high-grade B-cell lymphoma initially presenting in bone marrow: a diagnostic challenge. Mod Pathol 35(3):419-426, 2022. e-Pub 2022. PMID: 34608246.
      22. Qiu L, Xu J, Tang G, Wang SA, Lin P, Ok CY, Garces S, Yin CC, Khanlari M, Vega F, Medeiros LJ, Li S. Mantle cell lymphoma with chronic lymphocytic leukemia-like features: a diagnostic mimic and pitfall. Hum Pathol 119:59-68, 2022. e-Pub 2022. PMID: 34767860.
      23. Qiu L, Medeiros LJ, Tang G, Khanlari M, Li S, Konoplev S, Wang SA, Yin CC, Khoury JD, Wang W, Miranda RN, Iyer S, You MJ, Xu J. The Leukemic Phase of ALK-Negative Anaplastic Large Cell Lymphoma Is Associated with CD7 Positivity, Complex Karyotype, TP53 Deletion, and a Poor Prognosis. Cancers (Basel) 13(24), 2021. e-Pub 2021. PMID: 34944936.
      24. El Hussein S, Wang W, Wang SA, Fang H, Garces S, Tashakori M, Lyapichev KA, Qiu L, Wang X, Loghavi S, Medeiros LJ, Challagundla P, Jorgensen JL. Hematogones with light chain restriction: A potential diagnostic pitfall when using flow cytometry analysis to assess bone marrow specimens. Leuk Res 111:106704, 2021. e-Pub 2021. PMID: 34735934.
      25. Qiu L, Tang G, Li S, Wang W, Wang SA, Xu J. Blast phase of chronic myeloid leukemia presenting as early T-cell precursor lymphoblastic leukemia. EJHaem 2(4):895-896, 2021. e-Pub 2021. PMID: 35845203.
      26. Qiu L, Weitzman SP, Nastoupil LJ, Williams MD, Medeiros LJ, Vega F. Disseminated ALK-positive histiocytosis with KIF5B-ALK fusion in an adult. Leuk Lymphoma 62(5):1234-1238, 2021. e-Pub 2021. PMID: 33353436.
      27. Taverna JA, Hung CN, DeArmond DT, Chen M, Lin CL, Osmulski PA, Gaczynska ME, Wang CM, Lucio ND, Chou CW, Chen CL, Nazarullah A, Lampkin SR, Qiu L, Bearss DJ, Warner S, Whatcott CJ, Mouritsen L, Wade M, Weitman S, Mesa RA, Kirma NB, Chao WT, Huang TH. Single-Cell Proteomic Profiling Identifies Combined AXL and JAK1 Inhibition as a Novel Therapeutic Strategy for Lung Cancer. Cancer Res 80(7):1551-1563, 2020. e-Pub 2020. PMID: 31992541.
      28. Qiu L, Volk E, Mais DD. Histopathologic Patterns of Colitis in Patients With Impaired Renal Function. Am J Clin Pathol 153(3):380-386, 2020. e-Pub 2020. PMID: 31679016.
      29. Qiu L, Mais DD, Nicolas M, Nanyes J, Kist K, Nazarullah A. Diagnosis of Papillary Breast Lesions on Core Needle Biopsy: Upgrade Rates and Interobserver Variability. Int J Surg Pathol 27(7):736-743, 2019. e-Pub 2019. PMID: 31187678.
      30. Lai WS, Stumpo DJ, Qiu L, Faccio R, Blackshear PJ. A Knock-In Tristetraprolin (TTP) Zinc Finger Point Mutation in Mice: Comparison with Complete TTP Deficiency. Mol Cell Biol 38(4), 2018. e-Pub 2018. PMID: 29203639.
      31. Qiu LQ, Lai WS, Stumpo DJ, Blackshear PJ. Measurement of mRNA Decay in Mouse Embryonic Fibroblasts. Bio Protoc 6(13), 2016. e-Pub 2016. PMID: 28516114.
      32. Qiu LQ, Lai WS, Stumpo DJ, Blackshear PJ. Mouse Embryonic Fibroblast Cell Culture and Stimulation. Bio Protoc 6(13), 2016. e-Pub 2016. PMID: 28573158.
      33. Qiu LQ, Lai WS, Bradbury A, Zeldin DC, Blackshear PJ. Tristetraprolin (TTP) coordinately regulates primary and secondary cellular responses to proinflammatory stimuli. J Leukoc Biol 97(4):723-36, 2015. e-Pub 2015. PMID: 25657290.
      34. Qiu LQ, Abey S, Harris S, Shah R, Gerrish KE, Blackshear PJ. Global analysis of posttranscriptional gene expression in response to sodium arsenite. Environ Health Perspect 123(4):324-30, 2015. e-Pub 2015. PMID: 25493608.
      35. Qiu LQ, Stumpo DJ, Blackshear PJ. Myeloid-specific tristetraprolin deficiency in mice results in extreme lipopolysaccharide sensitivity in an otherwise minimal phenotype. J Immunol 188(10):5150-9, 2012. e-Pub 2012. PMID: 22491258.
      36. Qiu LQ, Cresswell P, Chin KC. Viperin is required for optimal Th2 responses and T-cell receptor-mediated activation of NF-kappaB and AP-1. Blood 113(15):3520-9, 2009. e-Pub 2009. PMID: 19047684.
      37. Qiu LQ, Sinniah R, Hsu SI. Role of differential and cell type-specific expression of cell cycle regulatory proteins in mediating progressive glomerular injury in human IgA nephropathy. Lab Invest 84(9):1112-25, 2004. e-Pub 2004. PMID: 15208647.
      38. Qiu LQ, Sinniah R, Hsu SI. Coupled induction of iNOS and p53 upregulation in renal resident cells may be linked with apoptotic activity in the pathogenesis of progressive IgA nephropathy. J Am Soc Nephrol 15(8):2066-78, 2004. e-Pub 2004. PMID: 15284293.
      39. Qiu LQ, Sinniah R, I-Hong Hsu S. Downregulation of Bcl-2 by podocytes is associated with progressive glomerular injury and clinical indices of poor renal prognosis in human IgA nephropathy. J Am Soc Nephrol 15(1):79-90, 2004. e-Pub 2004. PMID: 14694160.
      40. Wu Z, Qiu L. Effect of nitric oxide on iron-mediated cytotoxicity in primary cultured renal proximal tubules. Cell Biochem Funct 19(4):237-47, 2001. e-Pub 2001. PMID: 11746204.
      41. Wu ZL, Liang MY, Qiu LQ. Oxidized low-density lipoprotein decreases the induced nitric oxide synthesis in rat mesangial cells. Cell Biochem Funct 16(3):153-8, 1998. e-Pub 1998. PMID: 9747506.

      Review Articles

      1. Qiu L, Lin P. Lymphoplasmacytic lymphoma and Waldenstrom macroglobulinemia, a decade after the discovery of MYD88(L265P). Hum Pathol:105708, 2024. e-Pub 2024. PMID: 39701426.
      2. Qiu L, Medeiros LJ, Li S. High-grade B-cell lymphomas: Double hit and non-double hit. Hum Pathol:105700, 2024. e-Pub 2024. PMID: 39603365.
      3. Qiu L, Wang SA, Vega F, Khoury JD, Tang Z, Garces S, Medeiros LJ, Thakral B. From the archives of MD Anderson Cancer Center: Intravascular large B-cell lymphoma with numerous circulating lymphoma cells. Ann Diagn Pathol 58:151934, 2022. e-Pub 2022. PMID: 35299081.
      4. Qiu L, Cho JH, Jelloul FZ, Vega F. SOHO State of the Art Updates and Next Questions: Pathology and Pathogenesis of Nodal Peripheral T-Cell Lymphomas. Clin Lymphoma Myeloma Leuk 22(5):287-296, 2022. e-Pub 2022. PMID: 34776400.

      Other Articles

      1. Rivera D, Cui W, Gao J, Peker D, Zhang QY, Dewar R, Qiu L, Konoplev S, Hu Z, Sasaki K, Hu AY, Shuyu E, Liu M, Fang H, Wang W, Tang G, Apperley JF, Hochhaus A, Cortes JE, Khoury JD, Medeiros LJ, Jabbour E, Hu S Corrigendum to "Aleukemic Chronic Myeloid Leukemia Without Neutrophilia and Thrombocytosis: A Report From the BCR::ABL1 Pathology Group" [Modern Pathology. 2024;37(2):100406]. Mod Pathol 39(2):100952, 2026. PMID: 41518888.
      2. Oak J, Furtado FM, Devitt KA, Horna P, Fromm JR, Qiu L, Illingworth A, Cardinali J, Kern W, Al-Attar A, Shi M A practical approach to panel design, validation, and interpretation for the evaluation of T-cell neoplasms by flow cytometry. Cytometry B Clin Cytom, 2025. PMID: 41122063.

      Editorials

      1. Qiu L. Genomic proximity mapping: a promising next generation cytogenomic assay for comprehensive assessment of acute myeloid leukemia. Haematologica, 2026. PMID: 41676907.

      Abstracts

      1. Shu C, Hu Z, Thakral B, Xu J, Qiu L, Medeiros LJ, Wang W, Wang SA. Integration of high-performance ai for accurate detection of measurable residual disease in acute myeloid leukemia. USCAP 2026 annual meeting, San Antonio, TX, March 21-26, 2026.
      2. Qiu LQ, Sinniah R, Hsu SIH.. Differential expression of interleukin-10 by glomerular epithelial cells and inflammatory cells in IgA nephropathy. International Society of Nephrology/ American Society of Nephrology World Congress of Nephrology, San Francisco USA, October 14-17, 2001.
      3. Qiu LQ, Sinniah R, Hsu SIH. Coordinated apoptotic and proliferative activity is associated with progressive tubulointerstitial fibrosis in human IgA nephropathy. 6th National University Singapore-National University Hospital Annual Scientific meeting, Singapore, August 16-17, 2002.
      4. Qiu LQ, Sinniah R, Hsu SIH. Role of cyclin-dependent kinase inhibitors on apoptotic and proliferative activity in glomeruli of IgA nephropathy. International Society of Nephrology/American Society of Nephrology World Congress of Nephrology, Philadelphia USA, November 4-8, 2002.
      5. Qiu LQ, Hsu SIH. Coupled induction of iNOS and p53 upregulation in renal resident cells may be linked with pro-apoptotic activity in the pathogenesis of progressive IgA nephropathy. International Society of Nephrology World Congress of Nephrology, Berlin, Germany, June 8-12, 2003.
      6. Qiu L, Lai WS, Blackshear PJ. Tristetraprolin coordinately regulates primary and secondary cellular responses to pro-inflammatory stimuli. 4th RNA Stability Meeting, RNA turnover and translation, Biological and Pathological Ramifications, Montreal, Canada, October 17-20, 2010.
      7. Stumpo DJ, Qiu LQ, Blackshear PJ. A tandem zinc finger protein, ZFP36L2, is required for the maintenance and self-renewal of murine hematopoietic stem cells. 4th RNA Stability Meeting, RNA turnover and translation, Biological and Pathological Ramifications, Montreal, Canada, October 17-20, 2010.
      8. Qiu L, Heim-Hall J. Nonphosphaturic variant of phosphaturic mesenchymal tumor, mixed connective tissue type: a case report. American Society for Clinical Pathology 2017 Annual Meeting, Chicago, Illinois, September 6-8, 2017.
      9. Bollmann F, Qiu LQ, Snyder BL, Shockley KR, Inglese J, Blackshear PJ. A quantitative high‐throughput screen to identify small molecules for the induction of tristetraprolin expression. the Experimental Biology 2018 Meeting, The FASEB Journal, April 2018.
      10. Qiu L, Nicolas MM, Mais DD, Nazarullah AN. Diagnosis of papillary breast lesions on core-needle biopsy: upgrade rate and inter-observer variability. TSP 97th Annual meeting, Houston, Texas, January 19-21, 2018.
      11. Qiu L, Crown S, Hemmi J, Greebon L. Safety evaluation of ABO-incompatible plasma containing components during emergency release transfusions. AABB 2018 annual meeting, Boston, Massachusetts, October 13-16, 2018.
      12. Qiu L, Volk EA, Mais DD. Histopathological patterns of colitis in patients with impaired renal function: a retrospective study of lower gastrointestinal tract. USCAP 2019 annual meeting, National Harbor, Maryland, March 16-21, 2019.
      13. Kim D, Qiu L, Medina E, Nazarullah A, Mais DD. Human immunodeficiency virus-associated lymphadenopathy and lymphoproliferations: the range of pathologic diagnoses in the time highly- active anti-retroviral therapy (HAART). USCAP 2019 annual meeting, National Harbor, Maryland, March 16-21, 2019.
      14. Qiu L, Wu, Medina E, Higgins R, Holder K. Aggressive systemic mastocytosis with associated hematologic neoplasm (chronic myelomonocytic leukemia). SH/EAHP Workshop 2019: addressing the challenges of eosinophilia and mastocytosis, Phoenix, AZ, September 12-14, 2019.
      15. Tantiwongkosi B, Lally J, Farrell JK, Qiu L, McGuff HS, Miller FR. Update in HPV-mediated Oropharyngeal Cancer Staging-AJCC 8th Edition. 2019 American Society of Head Neck Radiology Annual Meeting, Scottsdale, Arizona, October 2-6, 2019.
      16. Tantiwongkosi B, Miller FR, Lally J, Farrel J, Qiu L, McGuff. Staging of Oral Cavity Cancers-Update 2018 AJCC 8th Edition. 2019 American Society of Head Neck Radiology Annual Meeting, Scottsdale, Arizona, October 2-6, 2019.
      17. Qiu L, Khanlari M, Li S, Tang G, Yin CC, Wang SA, Iyer S, You MJ, Konoplev S, Miranda RN, Medeiros LJ, Xu J. Leukemic ALK-negative ALCL is characterized by thrombocytopenia, bone marrow involvement, CD7 positivity, complex karyotype, and a poor prognosis. USCAP 2021 annual meeting, Virtual and Interactive, March 13-18, 2021.
      18. Khanlari M, Lin P, Xu J, You MJ, Tang G, Yin CC, Qiu L, Bueso-Ramos CE, Medeiros LJ, Li S. Blastoid Large B Cell Lymphoma with Primary Bone Marrow Presentation: A Diagnostic Challenge. USCAP 2021 annual meeting, Virtual and Interactive, March 13-18, 2021.
      19. Qiu L, Li S. Blastoid and leukemic transformation of mantle cell lymphoma. SH/EAHP 2021 workshop, Philadelphia, PA, November 4-6, 2021.
      20. Qiu L, Tang G, Xu J, McDonald T, Miranda RN, Khanlari M, Medeiros LJ, Li S. Prolymphocytic transformation of CD5-negative, cyclin D1-positive splenic low-grade B cell lymphoma. SH/EAHP 2021 workshop, Philadelphia, PA, November 4-6, 2021.
      21. Qiu L, Khanlari M, Li S. Blastoid transformation of CCND1-negative mantle cell lymphoma. SH/EAHP 2021 workshop, Philadelphia, PA, November 4-6, 2021.
      22. Qiu L, Tang G, Li S, Lin P, Wang SA, Konoplev S, Miranda RN, Iyer S, Wang W, Medeiros LJ, Xu J. DUSP22-rearrangement is associated with younger age, unique immunophenotype, and minimal expression of PD-L1 and pSTAT3, but not prognosis in patients with systemic ALK-negative anaplastic large cell lymphoma. USCAP 2022 annual meeting, Los Angeles, CA, March 19-24, 2022.
      23. Qiu L, Garcia-Manero G, Montalban-Bravo G, Yang H, Tang Z, Patel K, Loghavi S, Ok CY, Bueso-Ramos C, Medeiros L, Kanagal-Shamanna R. Somatic U2AF1 mutations involving codons Q157 and S34 are associated with distinct clinical and molecular characteristics but similar outcomes in patients with myelodysplastic syndrome. USCAP 2022 annual meeting, Los Angeles, CA, March 19-24, 2022.
      24. Qiu L, Khanlari M, Tang G, Xu J, Lin P, Khoury JD, Konoplev S, Garces S, Wang SA, Wang W, Medeiros LJ, Li S. Clinicopathologic and cytogenetic features of blastoid high-grade B-cell lymphoma. USCAP 2022 annual meeting, Los Angeles, CA, March 19-24, 2022.
      25. Qiu L, Lin P, Quesada, AE. Plasma cell leukemia with small morphology and lacking paraproteinemia, mimicking acute lymphoblastic leukemia. EAHP2022, Florence, Italy, September 17-22, 2022.
      26. Marques-Piubelli ML, Hancco DD, Qiu L, Nahmod KA, Cho JH, Jiang M, McAllen SA, Solis LM, Steiner R, Pinnix C, Wistuba II, Cuentas EP, Vega F. EOMES+ Tr1-like Cells are Enriched in areas of NLPHL Group II (Patterns D to F) Supporting the Role of Tregs in Disease Progression. ASH 2022 New Orleans, LA, December 10–13, 2022.
      27. Aakash FNU, Medeiros LJ, Qiu L, Xu J, Lin P, You MJ, Li S. Cases with Burkitt Lymphoma morphology and an atypical immunophenotype or complex karyotype: are they Burkitt Lymphoma?. USCAP 2023 annual meeting, New Orleans, LA, March 11-16, 2023.
      28. Kim DH, Medeiros LJ, Xu J, Tang G, Qiu L, Wang SA, Ok CY, Wang W, Yin CC, You MJ, Garces S, Lin P, Li S. MYC and BCL6 Double Hit Lymphoma (DHL): A clinicopathologic study of 60 cases in comparison to BCL2-DHL and Diffuse Large B-cell Lymphoma (DLBCL). USCAP 2023 annual meeting, New Orleans, LA, March 11-16, 2023.
      29. Das M, Cherian S, Ally F, Qiu L. Hepatosplenic T-cell lymphoma with unusual presentations of leukemic disease, lymphadenopathy and splenic pseudo-aneurysms. SH-EA4HP workshop, Houston, Texas, November 9-11, 2023.
      30. Gong Z, Qiu L, DiGiuseppe J, Xue M, Soma L, Wang W, Zhou Y, Zhu M, Naik A, Chen W, Wang WJ, Wang SA, Medeiros, LJ, Jabbour E, Kantarjian HM, Cartes JE, Radich JP, Khoury JD, Hochhaus A, Apperley JF, Chen S, Naresh KN, Hu S. Does Detection of <20% Lymphoblasts in Patients with CML Herald Imminent Blast Crisis? a Study from BCR::ABL1 Pathology Group. ASH 2023, San Diego, California, December 9-12, 2023.
      31. Qiu L, Naresh KN, Chen X. Pseudo-Richter transformation in an otherwise clinically silent chronic lymphocytic leukemia/small lymphocytic lymphoma patient following temporal acalabrutinib interruption. SH-EA4HP workshop, Dubrovnik, Croatia, September 21-26, 2024.
      32. Qiu L, Ding Y, Zhang R, Naresh KN, Chen X. An unusual case of primary marginal zone lymphoma of class-switched type, IgG4-positive, presenting with skin and conjunctival lesions. SH-EA4HP workshop, Dubrovnik, Croatia, September 21-26, 2024.
      33. Chen X, Hyun T, Qiu L, Naresh KN. A patient with CLL/SLL who developed HLH/MAS post CAR-T-cell infusion. SH-EA4HP workshop, Dubrovnik, Croatia, September 21-26, 2024.
      34. Wang WJ, Tang G, Medeiros LJ, Li S, Lin P, Wang SA, Wang W, Shuai W, Khoury JD, Castillo LM, Qiu L, Fang H, Wei Q, Vega F, Xu J. TP53 Deletion in systemic ALK-negative anaplastic large cell lymphoma is associated with leukemic disease and cytoplasmic CD3 expression and has prognostic significance in a subset of patients. USCAP 2025 annual meeting, Boston, MA, March 22-27, 2025.
      35. Qiu L, Tang G, Muzzafar T, Medeiros LJ, Bueso-Ramos C, Thakral B. KMT2A-rearranged acute megakaryoblastic leukemia mimicking atypical lymphocytes in blood and idiopathic thrombocytopenic purpura. SH-EA4HP workshop, Cincinnati, Ohio, September 4-6, 2025.
      36. Hussain MF, Ghosh A, Qiu L. Pulmonary mucosa-associated lymphoid tissue (MALT) lymphoma with extensive plasmacytic differentiation and clonal IgG4 overproduction. Texas Society of Pathologists 105th annual meeting, Dalla, TX, January 23-25, 2026.

      Book Chapters

      1. Qiu L, Yeung CCS. Chapter 8: Overview of Myeloid Neoplasms. In: The Washington Manual of Hematopathology. First. Wolters Kluwer, 2024.
      2. Wang WJ, Xu J, Wang SA, Qiu L, Li S. Chapter 40: Systemic mastocytosis. In: Flow Cytometry in Hematolymphoid Neoplasms: A comprehensive and Practical Guide. Cambridge University Press.
      3. Qiu L, Li S, Lin P, Zhou J, Zhou Y, Xu J. Chapter 7: Large B-cell lymphoma with plasmablastic differentiation. In: Flow Cytometry in Hematolymphoid Neoplasms: A comprehensive and Practical Guide. Cambridge University Press.
      4. Li S, Xu J, Qiu L. Chapter 6: Aggressive B-cell lymphomas. In: Flow Cytometry in Hematolymphoid Neoplasms: A comprehensive and Practical Guide. Cambridge University Press.

      Letters to the Editor

      1. Qiu L, Xu J, Lin P, Cohen EN, Tang G, Wang SA, Khanlari M, Wang W, Khoury JD, Konoplev S, Yin CC, Jorgensen JL, Vega F, Medeiros LJ, Li S. Unique pathologic features and gene expression signatures distinguish blastoid high-grade B-cell lymphoma from B-acute lymphoblastic leukemia/lymphoma. Haematologica 108: 895-899, 2023.
      2. El Hussein S, Wang W, Wang SA, Loghavi S, Wang X, Qiu L, Fang H, Medeiros LJ, Aung PP, Torres Cabala C, Jorgensen JL, Pemmaraju N, Khoury JD. Blastic plasmacytoid dendritic cell neoplasm with history of myeloma and concomitant acute undifferentiated leukemia: Illustration of morphologic and immunophenotypic challenges of an emerging phenomenon. Leuk Lymphoma 62: 3296-3299, 2021.
      Read More
      Less

      Patient Reviews


      CV information above last modified July 22, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top